Literature DB >> 23413122

Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells.

Margarita González del Pliego1, Elsa Aguirre-Benítez, Karina Paisano-Cerón, Irene Valdovinos-Ramírez, Carlos Rangel-Morales, Verónica Rodríguez-Mata, Carmen Solano-Agama, Dolores Martín-Tapia, María Teresa de la Vega, Miguel Saldoval-Balanzario, Javier Camacho, María Eugenia Mendoza-Garrido.   

Abstract

Pituitary adenomas can invade surrounded tissue, but the mechanism remains elusive. Ether à go-go-1 (Eag1) potassium channel and epidermal growth factor receptors (ErbB1 and ErbB2) have been associated to invasive phenotypes or poor prognosis in cancer patients. However, cells arrange their cytoskeleton in order to acquire a successful migration pattern. We have studied ErbBs and Eag1 expression, and cytoskeleton arrangements in 11 human pituitary adenomas. Eag1, ErbB1 and ErbB2 expression were studied by immunochemistry in tissue and cultured cells. The cytoskeleton arrangement was analyzed in cultured cells by immunofluorescence. Normal pituitary tissue showed ErbB2 expression and Eag1 only in few cells. However, Eag1 and ErbB2 were expressed in all the tumors analyzed. ErbB1 expression was observed variable and did not show specificity for a tumor characteristic. Cultured cells from micro- and macro-adenomas clinically functional organize their cytoskeleton suggesting a mesenchymal pattern, and a round leucocyte/amoeboid pattern from invasive clinically silent adenoma. Pituitary tumors over-express EGF receptors and the ErbB2 repeated expression suggests is a characteristic of adenomas. Eag 1 was express, in different extent, and could be a therapeutic target. The cytoskeleton arrangements observed suggest that pituitary tumor cells acquire different patterns: mesenchymal, and leucocyte/amoeboid, the last observed in the invasive adenomas. Amoeboid migration pattern has been associated with high invasion capacity.

Entities:  

Keywords:  Eag1; ErbBs; Pituitary adenomas; cell culture; cytoskeleton; invasion

Mesh:

Substances:

Year:  2013        PMID: 23413122      PMCID: PMC3563198     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  Cell migration--movin' on.

Authors:  A R Horwitz; J T Parsons
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

Review 2.  Proteolytic and non-proteolytic migration of tumour cells and leucocytes.

Authors:  Peter Friedl; Katarina Wolf
Journal:  Biochem Soc Symp       Date:  2003

3.  Immunohistochemical distribution of simple-epithelial-type keratins and other intermediate filament proteins in the developing human pituitary gland.

Authors:  H Ikeda; T Yoshimoto
Journal:  Cell Tissue Res       Date:  1991-10       Impact factor: 5.249

Review 4.  Expression and function of ErbB receptors and ligands in the pituitary.

Authors:  Odelia Cooper; George Vlotides; Hidenori Fukuoka; Mark I Greene; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

5.  Intermediate filaments in the human pituitary gland: an immunohistochemical study.

Authors:  W C Halliday; S L Asa; K Kovacs; B W Scheithauer
Journal:  Can J Neurol Sci       Date:  1990-05       Impact factor: 2.104

6.  Intermediate filament expression in pituitary adenomas.

Authors:  A Ogawa; S Sugihara; M Hasegawa; A Sasaki; Y Nakazato; T Kawada; S Ishiuchi; M Tamura
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

Review 7.  Pituitary tumour clonality revisited.

Authors:  R N Clayton; W E Farrell
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

8.  Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas.

Authors:  Onder Onguru; Bernd W Scheithauer; Kalman Kovacs; Sergio Vidal; Long Jin; Shuya Zhang; Katharina H Ruebel; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2004-07       Impact factor: 7.842

9.  Clonal origin of pituitary adenomas.

Authors:  V Herman; J Fagin; R Gonsky; K Kovacs; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

10.  Autoregulation of tubulin synthesis in hepatocytes and fibroblasts.

Authors:  J M Caron; A L Jones; M W Kirschner
Journal:  J Cell Biol       Date:  1985-11       Impact factor: 10.539

View more
  8 in total

1.  Inhibition of 15-lipoxygenase (15-LOX) reverses hypoxia-induced down-regulation of potassium channels Kv1.5 and Kv2.1Inhibition of 15-lipoxygenase (15-LOX) reverses hypoxia-induced down-regulation of potassium channels Kv1.5 and Kv2.1.

Authors:  Wenjuan Liu; Di Wang; Kaibin Song; Li Chen; Yanmei Zhu; Peifang Liu; Yulan Zhu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 2.  Kv10.1 K(+) channel: from physiology to cancer.

Authors:  Halima Ouadid-Ahidouch; Ahmed Ahidouch; Luis A Pardo
Journal:  Pflugers Arch       Date:  2016-01-08       Impact factor: 3.657

3.  GH3 tumor pituitary cell cytoskeleton and plasma membrane arrangement are determined by extracellular matrix proteins: implications on motility, proliferation and hormone secretion.

Authors:  Erika Azorín; Beatriz Romero-Pérez; Carmen Solano-Agama; María T de la Vega; César G Toriz; Blanca Reyes-Márquez; Sirenia González-Pozos; Víctor H Rosales-García; Margarita González Del Pliego; Myrna Sabanero; María E Mendoza-Garrido
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-07-12

4.  The Stem Cell Connection of Pituitary Tumors.

Authors:  Hugo Vankelecom; Heleen Roose
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-04       Impact factor: 5.555

Review 5.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

Review 6.  Potassium channels in cell cycle and cell proliferation.

Authors:  Diana Urrego; Adam P Tomczak; Farrah Zahed; Walter Stühmer; Luis A Pardo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

7.  Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells.

Authors:  Diana Urrego; Naira Movsisyan; Roser Ufartes; Luis A Pardo
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  Whole-exome sequencing identifies variants in invasive pituitary adenomas.

Authors:  Xiaolei Lan; Hua Gao; Fei Wang; Jie Feng; Jiwei Bai; Peng Zhao; Lei Cao; Songbai Gui; Lei Gong; Yazhuo Zhang
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.